cipremi

remdesivir: Indian demand for COVID-19 drug remdesivir rising sharply: Cipla

MedicaloidNovember 9, 2020

November 9, 2020

BENGALURU: Demand for COVID-19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts...

Load more posts

cipremi

remdesivir: Indian demand for COVID-19 drug remdesivir rising sharply: Cipla

3 Basic Moves for a Whole-body Kettlebell Workout...

To Build Emotional Strength, Expand Your Brain

Listen: Plasma and Immunity

Bengaluru: Aam Aadmi party clinic offers free treatment

Keto Egg Wrap with Collard Greens Recipe, 3...

First U.S. case of highly transmissible Brazil coronavirus variant identified in Minnesota

Biden moving to nix Trump plan on opioid-recovery prescriptions

Onward and Upward for Single-Use Systems in Bioprocessing

Flaming Lips Use of Plastic Bubbles at Concerts Leave Covid-19 Experts Unsure

2 Trials Support Safety of Philips’ Stellarex DCB

A vaccine ad invokes the culture of Mardi Gras to reduce hesitancy.

FDA Adds New Tools for Evaluating Medical Devices

Here’s why West Virginia is a leader in the U.S. vaccine rollout.

Vercise Genus Deep Brain Stimulation for Parkinson’s FDA Approved

Biden Is Now in a Race: Vaccination vs. the Variants